<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phkinetica</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакокинетика и Фармакодинамика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacokinetics and Pharmacodynamics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7836</issn><issn pub-type="epub">2686-8830</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2587-7836-2020-2-4-10</article-id><article-id custom-type="elpub" pub-id-type="custom">phkinetica-242</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ ФАРМАКОДИНАМИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRECLINICAL PHARMACODYNAMICS STUDIES</subject></subj-group></article-categories><title-group><article-title>Нейропротекторные свойства in vitro новых глипролинов, замещённых по N-концу</article-title><trans-title-group xml:lang="en"><trans-title>The in vitro neuroprotective activity of analogues of N-terminus substituted glyprolines</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4584-746X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Николаев</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikolaev</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Николаев Сергей Владимирович – н. с. лаборатории фармакологии нейропротекции. SPIN-код: 7723-6008</p><p>Москва</p></bio><bio xml:lang="en"><p>Nikolaev Sergey V. – Research Scientist, Neuroprotection pharmacology laboratory. SPIN code: 7723-6008</p><p>Moscow</p></bio><email xlink:type="simple">cergej.nikolajev@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6101-1035</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Логвинов</surname><given-names>И. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Logvinov</surname><given-names>I. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Логвинов Илья Олегович – н. с. лаборатории фармакологии нейропротекции. SPIN-код: 9909-9630</p><p>Москва</p></bio><bio xml:lang="en"><p>Logvinov Ilya O. – Research Scientist, Neuroprotection pharmacology laboratory. SPIN code: 9909-9630</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6797-692X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колясникова</surname><given-names>К. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Koliasnikova</surname><given-names>K. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колясникова Ксения Николаевна – н. с. лаборатории пептидных биорегуляторов отдела химии лекарственных средств. SPIN-код: 5682-2035</p><p>Москва</p></bio><bio xml:lang="en"><p>Koliasnikova Ksenia N. – Research Scientist, Laboratory of peptide bioregulators, Department of medicinal chemistry. SPIN code: 5682-2035</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9228-0596</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetsova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузнецова Елена Александровна – к. х. н., с. н. с. лаборатории тонкого органического синтеза отдела химии лекарственных средств</p><p>Москва</p></bio><bio xml:lang="en"><p>Kuznetsova Elena A. –PhD, Senior Research Scientist, Laboratory of fine organic synthesis, Department of medicinal chemistry</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6093-8805</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антипов</surname><given-names>П. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Antipov</surname><given-names>P. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Антипов Пётр Иванович – к. х. н., с. н. с. лаборатории пептидных биорегуляторов отдела химии лекарственных средств. SPIN-код: 2591-3379</p><p>Москва</p><p> </p></bio><bio xml:lang="en"><p>Antipov Petr I. – PhD, Senior Research Scientist, Laboratory of peptide bioregulators, Department of medicinal chemistry. SPIN code: 2591-3379</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9309-4872</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антипова</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Antipova</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Антипова Татьяна Алексеевна – к. б. н., заведующая лабораторией фармакологии нейропротекции. SPIN-код: 7723-6008</p><p>Москва</p></bio><bio xml:lang="en"><p>Antipova Tatyana A. – PhD, Head Neuroprotection pharmacology laboratory. SPIN-код: 7723-6008</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «НИИ фармакологии имени В.В. Закусова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBI «Zakusov Institute of Pharmacology»</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>01</day><month>12</month><year>2020</year></pub-date><volume>0</volume><issue>2</issue><fpage>4</fpage><lpage>10</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Николаев С.В., Логвинов И.О., Колясникова К.Н., Кузнецова Е.А., Антипов П.И., Антипова Т.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Николаев С.В., Логвинов И.О., Колясникова К.Н., Кузнецова Е.А., Антипов П.И., Антипова Т.А.</copyright-holder><copyright-holder xml:lang="en">Nikolaev S.V., Logvinov I.O., Koliasnikova K.N., Kuznetsova E.A., Antipov P.I., Antipova T.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacokinetica.ru/jour/article/view/242">https://www.pharmacokinetica.ru/jour/article/view/242</self-uri><abstract><p>В работе была исследована нейропротекторная активность аналогов замещённого глипролина ГЗК-111 по N-концу in vitro. Окислительный стресс, вызванный Н2О2 (1,5 мM) приводил к достоверному снижению жизнеспособности гиппокампальных клеток линии НТ-22. Этиловый эфир N-фенилпропионил-глицил-L-пролина (ГЗК-45) защищал клетки от гибели при внесении как за 24 часа до, так и сразу после повреждения в концентрации 10–5–10–6 М. Соединения с ацетильным (ГЗК-49) и капроноильным (ГЗК-46) остатками по N-концу не обладали защитным действием ни в одной из схем эксперимента. ГЗК-45 также был эффективен на модели индуцированного 6-гидроксидофамином повреждения клеток нейробластомы человека линии SH-SY5Y.</p></abstract><trans-abstract xml:lang="en"><p>In this work investigated the neuroprotective activity of analogues of substituted glyproline GZK-111 at the N-terminus in vitro. Oxidative stress caused by H2O2 (1.5 mM) led to significant decrease in the hippocampal cells HT-22 viability. The ethyl ester N-phenypropionyl-glycyl-proline (GZK-45) was effective at the concentrations up to 10–6 M in both experimental schemes. The compounds with N-acethyl (GZK-49) and N-capronoyl (GZK-46) fragments did not protective effect in both experimental schemes. GZK-45 also had protective effect in the 6-hydroxydopamine induced damage of SH-SY5Y neuroblastoma cells.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>цикло-L-пролилглицин</kwd><kwd>окислительный стресс</kwd><kwd>6-гидроксидофамин</kwd><kwd>НТ-22</kwd><kwd>SH-SY5Y</kwd><kwd>ГЗК-45</kwd><kwd>ГЗК-46</kwd><kwd>ГЗК-49</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cyclo-L-prolylglycine</kwd><kwd>oxydative stress</kwd><kwd>6-hydroxydopamine</kwd><kwd>HT-22</kwd><kwd>SH-SY5Y</kwd><kwd>GZK-45</kwd><kwd>GZK-46</kwd><kwd>GZK-49</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gudasheva TA, Boyko SS, Akparov VKh et al. Identification of a novel endogenous memory facilitating cyclic dipeptide cyclo-prolylglycine in rat brain. FEBS Letters. 1996;391:149–152. DOI: 10.1016/0014-5793(96)00722-3</mixed-citation><mixed-citation xml:lang="en">Gudasheva TA, Boyko SS, Akparov VKh et al. Identification of a novel endogenous memory facilitating cyclic dipeptide cyclo-prolylglycine in rat brain. FEBS Letters. 1996;391:149–152. DOI: 10.1016/0014-5793(96)00722-3</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Гудашева Т.А., Островская Р. У., Трофимов С.С. и др. Новый эндогенный дипептид циклопролилглицин подобен пирацетаму по селективности мнемотропного эффекта // Бюллетень экспериментальной биологии и медицины. – 1999. – Т. 128 – № 10. – С. 411–413.</mixed-citation><mixed-citation xml:lang="en">Gudasheva TA, Ostrovskaya RU, Trofimov SS et al. New endogenous dipeptide cycloprolyl-glycine is similar to Piracetam by its mnemotropic selectivity. Bulletin Of Experimental Biology And Medicine. 1999;128(4):10121014. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гудашева Т.А., Константинопольский М.А., Островская Р.У., Середенин С.Б., Анксиолитическая активность эндогенного ноотропа цикло-пролилглицина в тесте приподнятого крестообразного лабиринта // Бюллетень экспериментальной биологии и медицины. – 2001. Т. 131. – № 5. – С. 547–550. DOI: 10.1023/A:1017928116025</mixed-citation><mixed-citation xml:lang="en">Gudasheva TA, Konstantinopol'skii MA, Ostrovskaya RU, Seredenin SB. Anxiolytic activity of endogenous nootropic dipeptide cycloprolylglycine in elevated plus-maze test. Bulletin of Experimental Biology and Medicine. 2001;131(5);464–466. (In Russ). DOI: 10.1023/A:1017928116025</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Колясникова К.Н., Гудашева Т.А., Назарова Г.А. и др. Сходство цикло-пролилглицина с пирацетамом по антигипоксическому и нейропротекторному эффектам // Экспериментальная и клиническая фармакология. – 2012. – Т. 75. – № 9. – С. 3–6.</mixed-citation><mixed-citation xml:lang="en">Kolyasnikova KN, Gudasheva TA, Nazarova GA et al. Similarity of Cycloprolylglycine to Piracetam in Antihypoxic and Neuroprotective Effects. Russian Journal of Experimental and Clinical Pharmacology. 2012;75(9);3–6. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Поварнина П.Ю., Колясникова К.Н., Николаев С.В. и др. Нейропептид циклопролилглицин проявляет нейропротективную активность при системном введении на модели неполной глобальной ишемии у крыс и в условиях глутаматной нейротоксичности in vitro // Бюллетень экспериментальной биологии и медицины. – 2015. Т. 160. – № 11. – С. 600–603. DOI: 10.1007/s10517-016-3241-5</mixed-citation><mixed-citation xml:lang="en">Povarnina PY, Kolyasnikova KN, Gudasheva TA et al. Neuropeptide cycloprolylglycine exhibits neuroprotective activity after systemic administration to rats with modeled incomplete global ischemia and in in vitro modeled glutamate neurotoxicity. Bulletin of Experimental Biology and Medicine. 2016;160(5):653–655. (In Russ). DOI: 10.1007/s10517-016-3241-5</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Гудашева Т.А., Григорьев В.В., Колясникова К.Н. и др. Нейропептид циклопролилглицин является эндогенным положительным модулятором AMPA-рецепторов // Доклады Академии наук. – 2016. Т. 471. – № 1. – С.106–108. DOI: 10.7868/s0869565216310273</mixed-citation><mixed-citation xml:lang="en">Gudasheva TA, Koliasnikova KN, Seredenin SB, et al. Neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors. Doklady akademii nauk. 2016;471(1):106–108. (In Russ). DOI: 10.7868/s0869565216310273</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Гудашева Т.А., Колясникова К.Н., и др. Нейропептид циклопролилглицин увеличивает содержание мозгового нейротрофического фактора в нейрональных клетках // Доклады Академии наук. – 2016 Т. 469 – № 4 – С.492–495. DOI: 10.1134/s160767291606003x</mixed-citation><mixed-citation xml:lang="en">Gudasheva TA, Koliasnikova KN, et al. Neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors. Doklady Biochemistry and Biophysics. 2016;471(1):387–389. (In Russ). DOI: 10.1134/s160767291606003x</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Антипова Т.А., Колясникова К.Н., Волкова Ю.С., и др. Нейропротекторные свойства in vitro новых замещённых глипролинов // Фармакокинетика и фармакодинамика. – 2018 – № 3. – С. 31–36. DOI: 10.24411/2587-7836-2018-10021</mixed-citation><mixed-citation xml:lang="en">Antipova TA, Kolyasnikova KN, Volkova YS, et al. Neuroprotective properties of novel substituted glyprolines in vitro. Farmakokinetika i farmakodinamika. 2018;(3):31–36. (In Russ). DOI: 10.24411/2587-7836-2018-10021</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гудашева Т.А., Колясникова К.Н., Кузнецова Е.А. и др. Этиловый эфир N-фенилацетил-глицил-L-пролина метаболизируется до циклоL-пролилглицина, проявляя сходный спектр нейропсихотропной активности // Химико-фармацевтический журнал. – 2016. – Т. 50. № 11. – С. 3–8. DOI: 10.1007/s11094-017-1516-4</mixed-citation><mixed-citation xml:lang="en">Gudasheva TA, Kolyasnikova KN, Kuznetsova EA, et al. N-Phenylacetylglycyl-L-Proline Ethyl Ester converts into Cyclo-LProlylglycine showing a similar spectrum of neuropsychotropic activity. Pharmaceutical Chemistry Journal. 2017; 50(11);705–710. (In Russ). DOI: 10.1007/s11094-017-1516-4</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gardner RR, Gellman SH. Secondary Effects in Flexible Hydrogen Bonding Networks. Pergamon. 1997;29:9881-9990. DOI: 10.1021/ja00146a038</mixed-citation><mixed-citation xml:lang="en">Gardner RR, Gellman SH. Secondary Effects in Flexible Hydrogen Bonding Networks. Pergamon. 1997;29:9881-9990. DOI: 10.1021/ja00146a038</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Jackson GR, Werrbach-Perez K, Ezell EL, et al. Nerve growth factor effects on pyridine nucleotides after oxidant injury of rat pheochromocytoma cells. Brain Research. 1992;592(1-2):239–248. DOI: 10.1016/0006-8993(92)91681-4</mixed-citation><mixed-citation xml:lang="en">Jackson GR, Werrbach-Perez K, Ezell EL, et al. Nerve growth factor effects on pyridine nucleotides after oxidant injury of rat pheochromocytoma cells. Brain Research. 1992;592(1-2):239–248. DOI: 10.1016/0006-8993(92)91681-4</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Riveles K, Luping ZH, Quik M. Cigarete smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells, Neurotoxicology. 2008;29(3):421– 427. DOI: 10.1016/j.neuro.2008.02.001</mixed-citation><mixed-citation xml:lang="en">Riveles K, Luping ZH, Quik M. Cigarete smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells, Neurotoxicology. 2008;29(3):421– 427. DOI: 10.1016/j.neuro.2008.02.001</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Twentyman PR, Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. British journal of cancer. 1987;56:279–285. DOI: 10.1038/bjc.1987.190</mixed-citation><mixed-citation xml:lang="en">Twentyman PR, Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. British journal of cancer. 1987;56:279–285. DOI: 10.1038/bjc.1987.190</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson GW, Zimmerman JE, Callahan FM. Reinvestigation of the mixed carbonic anhydride method of peptide synthesis. J. Am. Chem. Soc. 1967;89:5012–5017. DOI: 10.1021/ja00995a032</mixed-citation><mixed-citation xml:lang="en">Anderson GW, Zimmerman JE, Callahan FM. Reinvestigation of the mixed carbonic anhydride method of peptide synthesis. J. Am. Chem. Soc. 1967;89:5012–5017. DOI: 10.1021/ja00995a032</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Baumann E. Ueber eine einfache Methode der Darstellung von Benzoësäureäthern. Ber. Dtsch. Chem. Ges., 1886;19:3218–3222. DOI: 10.1002/CBER.188601902348</mixed-citation><mixed-citation xml:lang="en">Baumann E. Ueber eine einfache Methode der Darstellung von Benzoësäureäthern. Ber. Dtsch. Chem. Ges., 1886;19:3218–3222. DOI: 10.1002/CBER.188601902348</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Brenner M, Huber W. Herstellung von α-Aminosäureestern durch Alkoholyse der Methylester. Helv. Chim. Acta. 1953;36:1109-1115. DOI: 10.1002/hlca.19530360522</mixed-citation><mixed-citation xml:lang="en">Brenner M, Huber W. Herstellung von α-Aminosäureestern durch Alkoholyse der Methylester. Helv. Chim. Acta. 1953;36:1109-1115. DOI: 10.1002/hlca.19530360522</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wyrsch P, Blenn C, Bader J, et al. Cell death and autophagy under oxidative stress: roles of poly(ADP-ribose) polymerases and Ca2+ . Molecular and Cell Biology. 2012;17:3541–3553. DOI: 10.1128/MCB.00437-12</mixed-citation><mixed-citation xml:lang="en">Wyrsch P, Blenn C, Bader J, et al. Cell death and autophagy under oxidative stress: roles of poly(ADP-ribose) polymerases and Ca2+ . Molecular and Cell Biology. 2012;17:3541–3553. DOI: 10.1128/MCB.00437-12</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
